SETD2 and neoplasm: 2-HG competitively inhibits α-ketoglutarate-dependent dioxygenases, leading to epigenetic disorders and cell differentiation blocks, and can also improve HIF-1 α level, induce angiogenesis, and mediate the escape and metastasis of tumor cells [29].